WO2002020556A3 - Haplotypes du gene gpr68 - Google Patents
Haplotypes du gene gpr68 Download PDFInfo
- Publication number
- WO2002020556A3 WO2002020556A3 PCT/US2001/028023 US0128023W WO0220556A3 WO 2002020556 A3 WO2002020556 A3 WO 2002020556A3 US 0128023 W US0128023 W US 0128023W WO 0220556 A3 WO0220556 A3 WO 0220556A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gpr68
- gene
- haplotypes
- disclosed
- haplotyping
- Prior art date
Links
- 102000054766 genetic haplotypes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 101150055137 GPR68 gene Proteins 0.000 abstract 2
- 101710164258 Ovarian cancer G-protein coupled receptor 1 Proteins 0.000 abstract 2
- 102000056566 human GPR68 Human genes 0.000 abstract 2
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000003205 genotyping method Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001288868A AU2001288868A1 (en) | 2000-09-07 | 2001-09-07 | Haplotypes of the gpr68 gene |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23085700P | 2000-09-07 | 2000-09-07 | |
US60/230,857 | 2000-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020556A2 WO2002020556A2 (fr) | 2002-03-14 |
WO2002020556A3 true WO2002020556A3 (fr) | 2004-11-25 |
Family
ID=22866847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/028023 WO2002020556A2 (fr) | 2000-09-07 | 2001-09-07 | Haplotypes du gene gpr68 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001288868A1 (fr) |
WO (1) | WO2002020556A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003266238A1 (en) * | 2002-08-05 | 2004-02-25 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) |
-
2001
- 2001-09-07 AU AU2001288868A patent/AU2001288868A1/en not_active Abandoned
- 2001-09-07 WO PCT/US2001/028023 patent/WO2002020556A2/fr active Application Filing
Non-Patent Citations (1)
Title |
---|
XU Y. ET AL: "Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14", GENOMICS, vol. 35, 1996, pages 397 - 402, XP002928274 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002020556A2 (fr) | 2002-03-14 |
AU2001288868A1 (en) | 2002-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002006294A3 (fr) | Haplotypes du gene mmp13 | |
WO2002026764A3 (fr) | Haplotypes du gene ccr6 | |
WO2002008425A3 (fr) | Haplotypes du gene adrb3 | |
WO2002020556A3 (fr) | Haplotypes du gene gpr68 | |
WO2002006446A3 (fr) | Haplotypes du gene edg6 | |
WO2001087904A3 (fr) | Haplotypes du gene gpr4 | |
WO2001090128A3 (fr) | Haplotypes du gene gpr3 | |
WO2002050098A3 (fr) | Haplotypes du gene du recepteur de la prolactine (prlr) | |
WO2002016399A3 (fr) | Haplotypes du gene tacr1 | |
WO2002032928A3 (fr) | Haplotypes du gene hrh1 | |
WO2002038587A3 (fr) | Haplotypes du gene grm8 | |
WO2002032924A3 (fr) | Haplotypes du gene chrm5 | |
WO2001090118A3 (fr) | Haplotypes du gene edn2 | |
WO2001090124A3 (fr) | Haplotypes du gene gpr31 | |
WO2002026766A3 (fr) | Haplotypes du gene sstr4 | |
WO2001096350A3 (fr) | Haplotypes du gene grm3 | |
WO2002012562A3 (fr) | Haplotypes du gene pla2g1b | |
WO2002036609A3 (fr) | Haplotypes du gene chrm4 | |
WO2002012561A3 (fr) | Haplotypes du gene or1g1 | |
WO2002030949A3 (fr) | Haplotypes du gene ltb4r | |
WO2002090378A3 (fr) | Haplotypes du gene de ces2 | |
WO2001087908A3 (fr) | Haplotypes du gene ccr3 | |
WO2002012499A3 (fr) | Haplotypes du gene ntf3 | |
WO2002026770A3 (fr) | Haplotypes du gene admr | |
WO2002002580A3 (fr) | Haplotypes du gene etfb |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |